July 2025 - Page 2 of 17

MondayJul 28, 2025 11:17 am

QualityStocksNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Showcases Drivers at Laguna Seca Java House Grand Prix of Monterey

SEGG Media (NASDAQ: SEGG, LTRYW), a technology company at the intersection of sports, entertainment and gaming, announced that Lottery.com and Sports.com-sponsored drivers Callum Ilott, Louis Foster and Sebastian Murray will compete at the Java House Grand Prix of Monterey at WeatherTech Raceway Laguna Seca. Foster, driving the #45 Droplight Honda for Rahal Letterman Lanigan Racing, enters the event with an average starting position of 8.4 over the last five races and aims to convert his strong qualifying pace into points. Ilott returns to the circuit where he secured his career-best IndyCar finish of P5 in 2023, while Murray makes his…

MondayJul 28, 2025 11:00 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Joins Exclusive Serie B Multi-Club Ownership Ranks, Juve Stabia Valuation Surges 245%

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company pursuing a multi-club ownership (MCO) strategy, has become the second MCO in Italy’s Serie B League alongside City Football Group, majority owned by Abu Dhabi United Group. Brera owns SS Juve Stabia, while City Group holds Palermo FC and Manchester City FC. Executive Chairman Daniel J. McClory said the Serie B owners’ meetings in Rome highlighted Brera’s integration into the league’s top ownership group. Juve Stabia, dubbed “The Second Team of Naples,” posted the highest market value increase in Serie B over the 2024-25 season, rising 245% to US$32 million from…

MondayJul 28, 2025 9:45 am

QualityStocksNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Completes Name and Ticker Change from Mullen Automotive

Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, announced that its previously disclosed name change from Mullen Automotive Inc. to Bollinger Innovations, Inc. is effective as of July 28, 2025, along with its new Nasdaq stock symbol “BINI.” The company stated the transition unifies its commercial Class 1, 3 and 4 vehicles under a single brand identity. CEO and Chairman David Michery said the move marks the completion of the company’s brand evolution while having no impact on its legal structure or operations. No shareholder action is required as a result of the changes. To view the full press release,…

MondayJul 28, 2025 9:45 am

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Highlights Rising Importance of Platinum in Electrical, Clean-Energy Applications

Platinum’s unique properties — exceptional conductivity, heat resistance and catalytic efficiency — make it indispensable across a range of electrical applications. Hydrogen fuel cells, particularly the proton exchange membrane variety, are one of the most promising sources of green energy production. PLG is a player in this emerging landscape, with a focus on the development of large-scale platinum group metal resources in the Bushveld Complex. As global industries search for scalable and sustainable energy solutions, platinum has emerged as a critical component in the future of electrical applications. Platinum Group Metals (NYSE American: PLG) (TSX: PTM), is well positioned to…

MondayJul 28, 2025 9:00 am

Clene Inc. (NASDAQ: CLNN) Offers Investors a Compelling Entry into the Growing ALS Market with Key FDA Milestones for Lead Drug Candidate

Clene is progressing toward a potential FDA accelerated approval for its ALS (Amyotrophic Lateral Sclerosis) drug CNM-Au8® in 2026, a market that is expected to reach $1.3 billion by 2034 with significant unmet need. Clene’s technology targets mitochondrial dysfunction, a novel approach to neurodegenerative diseases, and key FDA meetings in the coming months of 2025 could be major valuation catalysts for investors. Biomarker and survival data from over 150 patients will be critical to the company’s regulatory case and expects important NfL data in the fourth quarter of 2025. Clene is preparing to initiate a confirmatory Phase 3 ALS trial…

MondayJul 28, 2025 9:00 am

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Appoints Dr. Lee T. Schalop to Board to Bolster AI-Driven Precision Oncology

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence and genomic data to accelerate oncology drug discovery, announced the appointment of Lee T. Schalop, MD, to its Board of Directors. Dr. Schalop, co-founder and former CEO of Oncoceutics Inc., brings over 20 years of experience in biotechnology leadership and financial markets, with a track record in developing targeted therapies for solid tumors, including HK327M-mutant gliomas. Oncoceutics was acquired by Chimerix Inc. (NASDAQ: CMRX) for $450 million in 2021 and later by Jazz Pharmaceuticals for $935 million in April 2025. Lantern CEO Panna Sharma said Dr. Schalop’s expertise in…

FridayJul 25, 2025 3:39 pm

QualityStocksNewsBreaks – Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Poised for Steady Production, Long-Term Success in British Columbia

Amid the rising value of precious metals, Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF) began processing high-grade gold and silver ore at its Merritt Mill facility, highlighting a key step forward in its growth. “Nicola expects to cumulatively process 60,000 (tn) of ore and produce 21,000 (oz) of gold-equivalent concentrate at full production capacity annual rate. The Merritt Mill provides accessible, reliable revenue to not only its British Columbian partners, but it also sustains its own copper, gold and silver projects across the province,” reads a recent article. “We are excited to realize that Nicola is morphing into a steady and…

FridayJul 25, 2025 3:29 pm

QualityStocksNewsBreaks – Ucore Rare Metals Inc.’s (TSX.V: UCU) (OTCQX: UURAF) RapidSX(TM) Core to Blueprint to Secure Rare Earth Independence

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is positioned as a key player in a strategy to build a secure, independent rare earth supply chain in North America. Triggered by China’s export restrictions on key elements, a potential blueprint includes diversifying rare earth sources, using modular refining with Ucore’s RapidSX(TM) technology, anchoring refining with magnet-making hubs, establishing stockpiles and off-take agreements, and proving the chain with traceability and ESG standards. Ucore’s RapidSX(TM) is central to reducing bottlenecks in chemical separation, helping to develop a resilient, transparent, and strategically independent supply chain. To view the full article, visit https://ibn.fm/TkGA1 About Ucore…

FridayJul 25, 2025 3:18 pm

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB): Innovation Meets Science Through Scalable Platform

Nutriband (NASDAQ: NTRB) is positioning at the forefront of abuse-deterrent drug delivery in advancing its flagship fentanyl patch and buprenorphine candidates. The company combines transdermal innovation with abuse-deterrent science to meet critical public health needs. According to Nurtiband, AVERSA Fentanyl, with the possibility to reach peak annual U.S. sales of $80 to $200 million, holds the potential to be the world’s first opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl patches. In addition, Nutriband is advancing AVERSA Buprenorphine, which upon approval is projected to achieve peak U.S. sales between…

FridayJul 25, 2025 3:10 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Builds Momentum to Bring New Hope to Neuro Patients

Clene (NASDAQ: CLNN), together with its subsidiary Clene Nanomedicine Inc., is preparing to initiate neurofilament biomarker analyses for its lead drug candidate CNM-Au8(R) in ALS, following feedback from the FDA during a recent Type C meeting. Slated for early Q4 2025, the analyses will assess changes in neurofilament light chain (“NfL”)—a recognized marker for neurodegeneration—among nearly 200 patients treated through the Expanded Access Program for CNM-Au8. “We are encouraged by the FDA’s collaborative approach and their constructive feedback on our NfL biomarker analysis plan from the ongoing NIH-sponsored EAP program,” said Benjamin Greenberg, MD, Head of Medical at Clene. “With…

Site Search

Company Search

Month: July 2025